Replies to post #14058 on CytoSorbents Corporation (CTSO)

[caesare74]

Tks Fantomphan for the hint. 2020 was mentioned by Dr. Chan to get the FDA approval. However, with a big pharma partnership, the FDA approval might come earlier. As we all know, small bio techs don't have a lobby in the FDA. Besides several big pharma, Novartis is a potential choice. Remember that Dr. Carl June was involved in the Kymriah licence deal to Novartis.

https://www.novartis.com/news/media-releases/kymriahr-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma

https://www.biospace.com/article/car-t-trailblazer-carl-june-who-collaborated-on-novartis-kymriah-makes-time-s-100-influential-list/